Country Trust Bank Eli Lilly & CO Transaction History

Country Trust Bank

$3.99 Billion
Q3 2024

A detailed history of Country Trust Bank transactions in Eli Lilly & CO stock. As of the latest transaction made, Country Trust Bank holds 95,627 shares of LLY stock, worth $71.5 Million. This represents 2.13% of its overall portfolio holdings.

Number of Shares

95,627

Previous 94,127 1.59%

Holding current value

$71.5 Million

Previous $85.2 Million 0.59%

% of portfolio

2.13%

Previous 2.2%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$772.14 - $960.02 $1.16 Million - $1.44 Million	1,500 Added 1.59%	95,627 $84.7 Million
Q2 2024 Jul 12, 2024	SELL	$724.87 - $909.04 $629,912 - $789,955	-869 Reduced 0.91%	94,127 $85.2 Million
Q1 2024 Apr 16, 2024	SELL	$592.2 - $792.28 $7.67 Million - $10.3 Million	-12,955 Reduced 12.0%	94,996 $73.9 Million
Q4 2023 Jan 08, 2024	SELL	$525.19 - $619.13 $6.68 Million - $7.88 Million	-12,724 Reduced 10.54%	107,951 $62.9 Million
Q3 2023 Oct 10, 2023	SELL	$434.7 - $599.3 $13.9 Million - $19.1 Million	-31,912 Reduced 20.91%	120,675 $64.8 Million
Q2 2023 Jul 12, 2023	SELL	$350.74 - $468.98 $14.6 Million - $19.6 Million	-41,765 Reduced 21.49%	152,587 $71.6 Million
Q1 2023 Apr 13, 2023	BUY	$310.63 - $364.82 $2.13 Million - $2.5 Million	6,865 Added 3.66%	194,352 $66.7 Million
Q4 2022 Jan 18, 2023	BUY	$321.55 - $374.67 $1.35 Million - $1.57 Million	4,197 Added 2.29%	187,487 $0
Q3 2022 Oct 20, 2022	BUY	$296.48 - $337.87 $504,905 - $575,392	1,703 Added 0.94%	183,290 $59.3 Million
Q2 2022 Jul 12, 2022	SELL	$278.73 - $327.27 $5.49 Million - $6.45 Million	-19,696 Reduced 9.79%	181,587 $58.9 Million
Q1 2022 Apr 25, 2022	BUY	$234.69 - $291.66 $4.22 Million - $5.24 Million	17,963 Added 9.8%	201,283 $57.6 Million
Q4 2021 Jan 26, 2022	BUY	$224.85 - $279.04 $1.36 Million - $1.68 Million	6,037 Added 3.41%	183,320 $50.6 Million
Q3 2021 Oct 26, 2021	SELL	$221.6 - $272.71 $415,278 - $511,058	-1,874 Reduced 1.05%	177,283 $41 Million
Q2 2021 Jul 19, 2021	SELL	$180.55 - $233.54 $163,036 - $210,886	-903 Reduced 0.5%	179,157 $41.1 Million
Q1 2021 Apr 16, 2021	SELL	$164.32 - $212.72 $489,016 - $633,054	-2,976 Reduced 1.63%	180,060 $33.6 Million
Q4 2020 Feb 03, 2021	BUY	$130.46 - $172.63 $54,793 - $72,504	420 Added 0.23%	183,036 $30.9 Million
Q3 2020 Oct 15, 2020	SELL	$146.22 - $169.13 $1.05 Million - $1.22 Million	-7,195 Reduced 3.79%	182,616 $27 Million
Q2 2020 Jul 27, 2020	SELL	$136.42 - $164.18 $4.02 Million - $4.84 Million	-29,463 Reduced 13.44%	189,811 $31.2 Million
Q1 2020 Apr 17, 2020	SELL	$119.05 - $147.35 $4.84 Million - $5.99 Million	-40,626 Reduced 15.63%	219,274 $30.4 Million
Q4 2019 Jan 08, 2020	BUY	$106.92 - $132.43 $1.58 Million - $1.96 Million	14,783 Added 6.03%	259,900 $34.2 Million
Q3 2019 Oct 10, 2019	BUY	$106.79 - $116.16 $4.47 Million - $4.86 Million	41,817 Added 20.57%	245,117 $27.4 Million
Q2 2019 Jul 11, 2019	SELL	$110.79 - $129.32 $223,463 - $260,838	-2,017 Reduced 0.98%	203,300 $22.5 Million
Q1 2019 Apr 17, 2019	SELL	$111.31 - $131.02 $9.51 Million - $11.2 Million	-85,443 Reduced 29.39%	205,317 $26.6 Million
Q4 2018 Feb 04, 2019	SELL	$105.9 - $118.64 $102,934 - $115,318	-972 Reduced 0.33%	290,760 $33.6 Million
Q3 2018 Nov 09, 2018	SELL	$85.86 - $107.31 $2.95 Million - $3.69 Million	-34,366 Reduced 10.54%	291,732 $31.3 Million
Q2 2018 Aug 10, 2018	BUY	$75.7 - $86.88 $4.24 Million - $4.87 Million	55,997 Added 20.73%	326,098 $27.8 Million
Q1 2018 May 08, 2018	SELL	$74.21 - $87.6 $1.05 Million - $1.24 Million	-14,197 Reduced 4.99%	270,101 $20.9 Million
Q4 2017 Jan 11, 2018	BUY	$81.94 - $87.89 $57,030 - $61,171	696 Added 0.25%	284,298 $24 Million
Q3 2017 Oct 31, 2017	BUY	$77.07 - $85.54 $21.9 Million - $24.3 Million	283,602	283,602 $24.3 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Country Trust Bank, based on Form 13F filings with the SEC.

News

Stay updated on Country Trust Bank with notifications on news.

Account

Country Trust Bank Eli Lilly & CO Transaction History